Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Leucadia National Corp. (LUK) A Good Stock To Buy?

Page 1 of 2

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George Soros hold the necessary resources and abilities to conduct an extensive stock analysis on small-cap stocks, which enable them to make millions of dollars by identifying potential winners within the small-cap galaxy of stocks. This represents the main reason why Insider Monkey takes notice of the hedge fund activity in these overlooked stocks.

Is Leucadia National Corp. (NYSE:LUK) ready to rally soon? Prominent investors are getting less optimistic. The number of long hedge fund bets shrunk by 3 recently. LUK was in 27 hedge funds’ portfolios at the end of the third quarter of 2015. There were 30 hedge funds in our database with LUK positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Barrick Gold Corporation (USA) (NYSE:ABX), HCC Insurance Holdings, Inc. (NYSE:HCC), and Willis Group Holdings PLC (NYSE:WSH) to gather more data points.

Follow Leucadia National Corp (NYSE:LUK)
Trade (NYSE:LUK) Now!

To most shareholders, hedge funds are assumed to be underperforming, outdated financial vehicles of the past. While there are more than 8000 funds with their doors open today, We choose to focus on the top tier of this club, approximately 700 funds. These money managers manage the majority of the smart money’s total asset base, and by tailing their unrivaled picks, Insider Monkey has unearthed a number of investment strategies that have historically defeated the broader indices. Insider Monkey’s small-cap hedge fund strategy outrun the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Now, let’s review the new action surrounding Leucadia National Corp. (NYSE:LUK).

What does the smart money think about Leucadia National Corp. (NYSE:LUK)?

At the end of the third quarter, a total of 27 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -10% from the previous quarter. With hedgies’ capital changing hands, there exists a few notable hedge fund managers who were upping their stakes substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Fairholme (FAIRX), managed by Bruce Berkowitz, holds the largest position in Leucadia National Corp. (NYSE:LUK). Fairholme (FAIRX) has an $206.8 million position in the stock, comprising 6% of its 13F portfolio. The second largest stake is held by First Pacific Advisors LLC, led by Robert Rodriguez and Steven Romick, holding an $184.6 million position; the fund has 1.6% of its 13F portfolio invested in the stock. Other professional money managers with similar optimism contain William Crowley, William Harker, and Stephen Blass’s Ashe Capital, Michael Lowenstein’s Kensico Capital and Allan Mecham and Ben Raybould’s Arlington Value Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!